Impact of Comorbidities on Health-related Quality of Life in Nontransplant Eligible Patients With Newly Diagnosed Multiple Myeloma
Hemasphere
.
2022 Jun 21;6(7):e744.
doi: 10.1097/HS9.0000000000000744.
eCollection 2022 Jul.
Authors
M Christine Bennink
1
2
,
Claudia A M Stege
3
,
Birgit I Lissenberg-Witte
4
,
Simone Oerlemans
5
,
Maarten R Seefat
3
,
Pieter Sonneveld
1
,
Sonja Zweegman
3
Affiliations
1
Department of Haematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
2
Department of Strategy, Amphia Hospital, Breda, the Netherlands.
3
Department of Haematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
4
Department of Epidemiology and Data Science, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, the Netherlands.
5
Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
PMID:
35813097
PMCID:
PMC9263484
DOI:
10.1097/HS9.0000000000000744
No abstract available